Navigation Links
Boston Scientific Announces Its ACC 2011 Schedule
Date:3/29/2011

ents regarding new product launches and launch cadence, regulatory approvals, clinical trials, product performance and competitive offerings.  If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements.  These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release.  As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.  

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and future business decisions made by us and our competitors.  All of these factors are difficult or impossible to predict accurately and many of them are beyond our control.  For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A – Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A – Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file hereafter.  We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. 
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Boston Scientific Receives FDA Approval of New Clik(TM) Anchor for Precision Plus(TM) Spinal Cord Stimulator System
2. Boston Scientific to Webcast Analyst Event
3. Boston Scientific to Present at Barclays Capital 2011 Global Healthcare Conference
4. Boston Scientific Announces European Approval and Launch of OMEGA™ Platinum Chromium Stent System
5. Unilife to Present at the 31st Annual Cowen Health Care Conference on Wednesday, March 9, 2011 in Boston
6. Boston Scientific Strengthens Structural Heart Product Portfolio By Completing Acquisition of Atritech
7. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Cowen and Company 31st Annual Health Care Conference in Boston on March 9, 2011
8. Nektar Therapeutics President and CEO Howard W. Robin to Present at the 31st Annual Cowen and Company Healthcare Conference in Boston
9. Boston Scientific Launches PROMUS® Element™ and TAXUS® Element™ Stent Systems in India
10. Boston Scientific to Participate in 2011 RBC Capital Markets Healthcare Conference
11. Boston Scientific Acquires Two Novel Technologies to Treat Peripheral Chronic Total Occlusions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... RnRMarketResearch.com adds "Pemphigus - ... of 68 pages with latest updates, data and ... The report "Pemphigus - Pipeline Review, H1 2015" report ... for Pemphigus , complete with comparative analysis at ... of action (MoA), route of administration (RoA) and ...
(Date:3/31/2015)... KENNEBUNK, Maine , March 31, 2015 /PRNewswire/ ... aggregated enrollment in Medicare Advantage (MA) plans in ... approximately 17.3 million people were enrolled in Medicare ... of more than 1.3 million members year-over-year.  54.3 ... the Centers for Medicare and Medicaid Services (CMS), ...
(Date:3/31/2015)...  SynCardia Systems, Inc. has received FDA approval to ... the effective use of its 50cc SynCardia temporary Total ... The FDA approval will allow SynCardia to launch ... patients. Patients enrolled in this study will receive the ... a donor heart transplant. (Caution-In the United States, ...
Breaking Medicine Technology:Pemphigus Therapeutic Development and Pipeline Review H1 2015 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 4Medicare Advantage Enrollment Reaches 17 Million According to Mark Farrah Associates 2FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 2FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 3FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 4
... 2011 Reportlinker.com announces that a new market ... Hospital Angiography Census ... most comprehensive European market report on the installed ... R&F, Angiography, CT, MRI,) and radiology IT systems ...
... China, Jan. 20, 2011 /PRNewswire-Asia/ -- Winner Medical ... Medical") a leading manufacturer of medical dressings, medical ... PurCotton® products in China, today announced that one ... ("Huanggang Cotton"), was recently awarded a Cotton Processing ...
Cached Medicine Technology:Reportlinker Adds Hospital Angiography Census 2Reportlinker Adds Hospital Angiography Census 3Winner Medical Obtains Cotton Processing Certificate from the State Development and Reform Commission 2Winner Medical Obtains Cotton Processing Certificate from the State Development and Reform Commission 3
(Date:3/31/2015)... Researchers at UC Davis have ... how human livers heal. The difference centers on ... Normally, mouse PPARa is far more active and ... quickly regenerate damaged livers. However, the research shows ... boost the regenerative effects of human PPARa. The ...
(Date:3/31/2015)... Mission, TX (PRWEB) March 31, 2015 One of ... would be a visit to Mount Kilauea on the big island. ... the few places where you can see molten lava slowly oozing ... spectacles on earth. , One place you would never ... in the flat, arid terrain of Mission, Texas -- until now. ...
(Date:3/31/2015)... 31, 2015 Indosoft, Inc., developers of ... the availability of SIP over TCP configuration for all SIP ... offering a full contact center ACD (Automatic Call ... Adding SIP over TCP support to all SIP devices gives ... The history of Voice over IP (VoIP) has primarily involved ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 National ... physical, social and psychological benefits of participating in ... thousands of adaptive sports athletes that adapt, believe ... encourage support for inclusive fitness and inclusive athletics ... in participating in adaptive sports and advocate for ...
(Date:3/31/2015)... March 31, 2015 Array Health ... technology, has announced that Lance Hood, Senior Director of ... Private Exchange Forum on April 1, 2015. The session, ... Benaissance, will address how employers can streamline and simplify ... , WHAT: “ Optimizing Employee and Employer Needs in ...
Breaking Medicine News(10 mins):Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 2Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 3Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 4Health News:Rare Volcano Constructed inside Gold’s Gym in Mission, Texas 2Health News:Rare Volcano Constructed inside Gold’s Gym in Mission, Texas 3Health News:Indosoft extends SIP over TCP support to User Extensions in its Q-Suite 5.9 Call Center Software 2Health News:April is National Adaptive Sports Month 2Health News:April is National Adaptive Sports Month 3Health News:Array Health’s Senior Director of Marketing to Co-Present with Benaissance at The Institute for HealthCare Consumerism Private Exchange Forum 2
... 2009 ,Potential Benefits of Intermittent Androgen Suppression Therapy ... of the Literature, is the title of an article ... European Urology , the official journal of the European ... the efficacy and tolerability of intermittent androgen deprivation (IAD) ...
... team made up of mental health professionals, emergency response ... has published the results of a study that shows ... Hurricane Katrina. The Category 3 storm ravaged the Gulf ... a recent issue of the Journal of the ...
... a multi-bed hospital room dramatically increases the risk of acquiring ... A new study led by infectious diseases expert Dr. Dick ... C. difficile ( Clostridium difficile ) rises with ... in a two, three or four-bedded room, each time you ...
... ,A new study shows that poor lung function ... factors, including birth weight, height, and gender. Researchers from Newcastle ... patients, all aged 14 years. Follow-up data also were obtained ... Results showed that several factors were related to poorer lung ...
... from the Society of Breast Imaging (SBI) and the ... published in the January issue of the Journal ... that breast cancer screening should begin at age 40 ... appropriate utilization of medical imaging modalities such as mammography, ...
... to sexual arousal, whereas in men, the responses of ... each other, according to Assistant Professor Meredith Chivers, from ... Michael Seto, Martin Lalumire, Ellen Laan, and Teresa Grimbos. ... ratings and physiological measures of sexual arousal in men ...
Cached Medicine News:Health News:Intermittent androgen deprivation at least as effective as continuous androgen deprivation 2Health News:Sharing a hospital room increases risk of 'super bugs' 2Health News:News briefs from the January issue of Chest 2Health News:New SBI and ACR recommendations suggest breast cancer screening should begin at age 40 2Health News:Women's bodies and minds agree less than men's on what's sexy 2
... for the mid- to high-volume lab, the ... can reduce time-consuming manual tasks by as ... performs random access, STAT, HCFA panels and ... including Stat chemistries, General chemistries, TDMs, DATs, ...
... on-board capacity of 57 assays ... 146 tests, the CX1000 PRO ... so you can maximize your ... workload. The CX1000 PRO creates ...
When it comes to providing speed, accuracy and menu flexibility, the SYNCHRON CX5 PRO has it all. The state-of-the-art CX5 PRO starts with the wide SYNCHRON chemistry menu to create the ideal full-se...
The leading fully automated system for plasma protein determinations. Third generation nephelometer combines reliability with highly cost-effective performance....
Medicine Products: